Sarepta Therapeutics (SRPT) EBT Margin Growth (3y) (2017 - 2026)
Sarepta Therapeutics (SRPT) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Sarepta Therapeutics |
1.61 Bn |
923.39 Mn |
291.52 Mn |
28,798.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
28,798.00 |
| Dec 31, 2025 |
-26,218.00 |
| Sep 30, 2025 |
7,482.00 |
| Jun 30, 2025 |
13,314.00 |
| Mar 31, 2025 |
18,564.00 |
| Dec 31, 2024 |
7,841.00 |
| Sep 30, 2024 |
3,257.00 |
| Jun 30, 2024 |
6,138.00 |
| Mar 31, 2024 |
12,395.00 |
| Dec 31, 2023 |
89,813.00 |
| Sep 30, 2023 |
86,310.00 |
| Jun 30, 2023 |
51,403.00 |
| Mar 31, 2023 |
-7,087.00 |
| Dec 31, 2022 |
43,408.00 |
| Sep 30, 2022 |
391.00 |
| Jun 30, 2022 |
18,379.00 |
| Mar 31, 2022 |
-38,530.00 |
| Dec 31, 2021 |
10,152.00 |
| Sep 30, 2021 |
7,290.00 |
| Jun 30, 2021 |
9,012.00 |
